Kineta’s $3 Million Registered Direct Offering

Orrick Herrington & Sutcliffe LLP represented Kineta on the matter. Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Sonia Carcano

Author: Sonia Carcano

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here